DIFFERENTIAL DIAGNOSIS OF JOINT SYNDROMES IN OUTPATIENT INTERNAL MEDICINE PRACTICE
Keywords:
joint syndrome; arthritis; arthralgia; differential diagnosis; early arthritis; synovitis; primary health care; rheumatology.Abstract
Joint pain and swelling occur in inflammatory, degenerative, crystal-induced, infectious, traumatic, endocrine, and systemic disorders; consequently, this symptom complex requires a structured differential diagnostic approach from the initial outpatient encounter. This article aims to summarize the diagnostic features of joint syndromes and present a clinically applicable initial assessment algorithm based on educational presentation materials and current clinical guidelines. A narrative analysis was conducted of the educational material and recommendations issued by EULAR, NICE, ACR, and EBJIS concerning early arthritis, rheumatoid arthritis, osteoarthritis, spondyloarthritis, gout, crystal-induced arthropathies, and septic arthritis. The synthesis indicated that the initial assessment should begin by excluding emergencies, confirming an intra-articular source of symptoms, and distinguishing inflammatory from mechanical pain patterns. The most informative elements include the combined findings from history taking, the distribution and number of affected joints, duration of morning stiffness, systemic and extra-articular features, and appropriately targeted laboratory and imaging investigations. Normal acute-phase reactants or negative rheumatoid factor and anti-cyclic citrullinated peptide antibodies do not exclude early inflammatory arthritis and should not delay referral to a rheumatologist. This article is a clinical review rather than a study of a patient sample; the source material contained no quantitative findings from a clinical cohort. The proposed algorithm is intended to support, not replace, clinical judgment and specialist consultation.
References
1.Joint Syndrome in Outpatient Internal Medicine Practice: Educational Presentation. Unpublished teaching material; the author and references supporting individual statements are not identified in the available copy. 2026.
2.Combe B, Landewé R, Daien CI, et al. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017;76(6):948–959. doi:10.1136/annrheumdis-2016-210602.
3.National Institute for Health and Care Excellence. Rheumatoid arthritis in adults: management. NICE guideline NG100. Published 2018; updated 2020. https://www.nice.org.uk/guidance/ng100.
4.National Institute for Health and Care Excellence. Osteoarthritis in over 16s: diagnosis and management. NICE guideline NG226. 2022. https://www.nice.org.uk/guidance/ng226.
5.National Institute for Health and Care Excellence. Spondyloarthritis in over 16s: diagnosis and management. NICE guideline NG65. 2017. https://www.nice.org.uk/guidance/ng65.
6.Ravn C, Neyt J, Benito N, et al. Guideline for management of septic arthritis in native joints (SANJO). J Bone Jt Infect. 2023;8(1):29–37. doi:10.5194/jbji-8-29-2023.
7.Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020;79(1):31–38. doi:10.1136/annrheumdis-2019-215315.
8.FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020;72(6):744–760. doi:10.1002/acr.24180.
9.Mandl P, D’Agostino MA, Navarro-Compán V, et al. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice. Ann Rheum Dis. 2024;83(6):752–759. doi:10.1136/ard-2023-224771.
10.Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584.
11.Colebatch AN, Edwards CJ, Østergaard M, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72(6):804–814. doi:10.1136/annrheumdis-2012-203158.
12.Dejaco C, Singh YP, Perel P, et al. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015;74(10):1799–1807. doi:10.1136/annrheumdis-2015-207492.
13.National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NICE guideline NG12. https://www.nice.org.uk/guidance/ng12.
14.Mackie SL, Dejaco C, Appenzeller S, et al. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary. Rheumatology (Oxford). 2020;59(3):487–494. doi:10.1093/rheumatology/kez672.
